{"id":943395,"date":"2026-03-10T16:10:37","date_gmt":"2026-03-10T20:10:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/"},"modified":"2026-03-10T16:10:37","modified_gmt":"2026-03-10T20:10:37","slug":"tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/","title":{"rendered":"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results"},"content":{"rendered":"<div class=\"mw_release\">\n<p>MALVERN, Pa., March  10, 2026  (GLOBE NEWSWIRE) &#8212; TELA Bio, Inc. (&#8220;TELA Bio&#8221;) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026. TELA Bio\u2019s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update.<\/p>\n<p>\n        <strong>Fourth Quarter Earnings Conference Call and Webcast Details<\/strong><br \/>\n        <br \/>Investors interested in listening to the conference call should <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9m0MrCt6fY4FF4qv50mE9sXNR2vRnXfnFfcKMZkz5rM-TiwLZW-qkhbXPo1IYX3xbEl5TbUlJjjVmbJhV4ZfzdejS0pTie6Smspe1JHQk3AXsyelNML5jKwInqWOzFSS\" rel=\"nofollow\" target=\"_blank\">register online<\/a>. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed via the <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VDFKQzw_RBOLQLV0pJXwdjSZgT6H-zeZdevDfg32Q-njzPuJDtXga4UDsMPYfeCWpD7SG6dFSsQj2K8Xsk8mdDo2VJ1UcyedZVX8fzu7XG33fx0mSkFG4VSceR9kXy4G\" rel=\"nofollow\" target=\"_blank\">Events &amp; Presentations<\/a> page of the investor section of TELA&#8217;s website.<\/p>\n<p>\n        <strong>About TELA Bio, Inc.<\/strong><br \/>\n        <br \/>TELA Bio, Inc. (NASDAQ: TELA) is a commercial-stage medical technology company focused on providing innovative technologies that optimize clinical outcomes by prioritizing the preservation and restoration of the patient&#8217;s own anatomy. The Company is committed to providing surgeons with advanced, economically effective soft-tissue reconstruction solutions that leverage the patient&#8217;s natural healing response while minimizing long-term exposure to permanent synthetic materials. For more information, visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=fuAr3JbU-Wlzhi5WnuZP9KbsBe8Jhp1FCRTIZk0ftDKEnszFW7UeCz-_4aE1MBlMNdrFnxXEqopd0NBFzG-41tJhquBVARbjdPgPQ3ujkQ8M2I09hrA0Uw4JxzmijtGTCvL4Svw5z94j15MuOKux1MZ9ZuY53SEqMU1Fq1oe4PiFhO4Osp9ukQNZgS3Rch0CpigcdQOkM3nT2049PZEjW6iCgqJydg3OPZR-jbcwT_BO8JJoXg7i3MPXnE94FWr3\" rel=\"nofollow\" target=\"_blank\"><u>www.telabio.com<\/u>.<\/a><\/p>\n<p>\n        <strong>Caution Regarding Forward-Looking Statements<\/strong><br \/>\n        <br \/>This press release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Words such as &#8220;may,&#8221; &#8220;might,&#8221; &#8220;will,&#8221; &#8220;should,&#8221; &#8220;believe,&#8221; &#8220;expect,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;continue,&#8221; &#8220;predict,&#8221; &#8220;forecast,&#8221; &#8220;project,&#8221; &#8220;plan,&#8221; &#8220;intend&#8221; or similar expressions, or statements regarding intent, belief, or current expectations are forward-looking statements and reflect the current beliefs of TELA Bio&#8217;s management. These statements are not guarantees of future performance and are subject to certain risks, uncertainties and other factors that could cause actual results and events to differ materially and adversely from those indicated by such forward-looking statements. These risks and uncertainties are described more fully in the &#8220;Risk Factors&#8221; section and elsewhere in our filings with the Securities and Exchange Commission and available at\u00a0<u><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Tnunpk6Eq1nvl6Ulfq_A7_DoJS_WEthcl4e8Yxc7eK9_fN7_o7KxH9TFFNL-rLJPfql4-0jpWXdd-fMQqZxQPw==\" rel=\"nofollow\" target=\"_blank\">www.sec.gov<\/a><\/u>,\u00a0including in our Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. Any forward-looking statements that we make in this announcement speak only as of the date of this press release, and TELA Bio assumes no obligation to update forward-looking statements whether as a result of new information, future events or otherwise after the date of this press release, except as required under applicable law.<\/p>\n<p>\n        <strong>Investor Contact<\/strong><br \/>\n        <br \/>Louisa Smith<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=YSzqUA5QHcDfXK19dto-gpBWfWv9uQAYHNgGhgZwGubzn0jUFUonCC6oHA9uRu0Z2KWvrQ6cW58QD-VeBXOlyw==\" rel=\"nofollow\" target=\"_blank\">ir@telabio.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/NWMwNTljZmUtNTY5YS00NmVhLTg3YWYtN2RiNTNmN2NjOTViLTExOTE3MDgtMjAyNi0wMy0xMC1lbg==\/tiny\/Tela-Bio-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>MALVERN, Pa., March 10, 2026 (GLOBE NEWSWIRE) &#8212; TELA Bio, Inc. (&#8220;TELA Bio&#8221;) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026. TELA Bio\u2019s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Fourth Quarter Earnings Conference Call and Webcast Details Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-943395","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"MALVERN, Pa., March 10, 2026 (GLOBE NEWSWIRE) &#8212; TELA Bio, Inc. (&#8220;TELA Bio&#8221;) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026. TELA Bio\u2019s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Fourth Quarter Earnings Conference Call and Webcast Details Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed &hellip; Continue reading &quot;TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-10T20:10:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results\",\"datePublished\":\"2026-03-10T20:10:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/\"},\"wordCount\":412,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/\",\"name\":\"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=\",\"datePublished\":\"2026-03-10T20:10:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/","og_locale":"en_US","og_type":"article","og_title":"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - Market Newsdesk","og_description":"MALVERN, Pa., March 10, 2026 (GLOBE NEWSWIRE) &#8212; TELA Bio, Inc. (&#8220;TELA Bio&#8221;) (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026. TELA Bio\u2019s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Fourth Quarter Earnings Conference Call and Webcast Details Investors interested in listening to the conference call should register online. Participants are required to register a day in advance or at minimum 15 minutes before the start of the call. A live webcast and replay can be accessed &hellip; Continue reading \"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/","og_site_name":"Market Newsdesk","article_published_time":"2026-03-10T20:10:37+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results","datePublished":"2026-03-10T20:10:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/"},"wordCount":412,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/","name":"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=","datePublished":"2026-03-10T20:10:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY2OTMyNSM3NDc3ODk1IzIxODAxMzk="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/tela-bio-to-announce-fourth-quarter-and-full-year-2025-financial-results\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"TELA Bio to Announce Fourth Quarter and Full Year 2025 Financial Results"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/943395","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=943395"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/943395\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=943395"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=943395"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=943395"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}